6-3076978-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001354930.2(RIPK1):c.155A>G(p.Asn52Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000529 in 1,550,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001354930.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIPK1 | NM_001354930.2 | c.155A>G | p.Asn52Ser | missense_variant | 2/11 | ENST00000259808.9 | NP_001341859.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIPK1 | ENST00000259808.9 | c.155A>G | p.Asn52Ser | missense_variant | 2/11 | 5 | NM_001354930.2 | ENSP00000259808 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000468 AC: 7AN: 149626Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000109 AC: 27AN: 248396Hom.: 0 AF XY: 0.0000968 AC XY: 13AN XY: 134362
GnomAD4 exome AF: 0.0000536 AC: 75AN: 1400542Hom.: 0 Cov.: 35 AF XY: 0.0000545 AC XY: 38AN XY: 697608
GnomAD4 genome AF: 0.0000468 AC: 7AN: 149626Hom.: 0 Cov.: 30 AF XY: 0.0000137 AC XY: 1AN XY: 73046
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2023 | The c.155A>G (p.N52S) alteration is located in exon 1 (coding exon 1) of the RIPK1 gene. This alteration results from a A to G substitution at nucleotide position 155, causing the asparagine (N) at amino acid position 52 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 18, 2023 | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 52 of the RIPK1 protein (p.Asn52Ser). This variant is present in population databases (rs149949748, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with RIPK1-related conditions. ClinVar contains an entry for this variant (Variation ID: 2164101). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at